Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NitroMed Prices BiDil At $5-$10 Per Day Wholesale Acquisition Cost

This article was originally published in The Pink Sheet Daily

Executive Summary

The heart failure therapy, which is approved for use in self-identified black patients, will arrive in pharmacies the week of July 11 with a wholesale acquisition cost of $1.80 per tablet. NitroMed is planning a patient assistance program for uninsured patients.

You may also be interested in...



NitroMed Plans Targeted BiDil Launch To Select Physicians; Sales Team Boasts Cardio Experience

BiDil launch targets physicians treating African-American heart failure patients over age 45. Sales force consists of reps with average 5.7 years cardiovascular sales experience.

NitroMed Plans Targeted BiDil Launch To Select Physicians; Sales Team Boasts Cardio Experience

BiDil launch targets physicians treating African-American heart failure patients over age 45. Sales force consists of reps with average 5.7 years cardiovascular sales experience.

NitroMed Ramps Up For Solo BiDil Launch In July

NitroMed’s 190-person sales force has begun detailing the heart failure therapy, according to CEO Loberg. The firm expects to launch BiDil in two to four weeks, without a partner. Labeling provides defense against generic substitution, Loberg says.

Topics

UsernamePublicRestriction

Register

LL1129367

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel